Company: KROS
Filing Date: 2025-02-26
Form Type: 10-K
Source: 0001664710-25-000018
Chunk: 169

Company: Keros Therapeutics, Inc.
Filing Date: 2025-02-26
Form: 10-K
Item: Item 15
Chunk 169
---
 LLC, dated March 20, 2017, as amended by the First Amendment to Lease Agreement by and between the registrant and 128 Spring Street Lexington, LLC, dated July 1, 2019 and by the Second Amendment to Lease Agreement by and between the registrant and 128 Spring Street Lexington, LLC, dated August 8, 2019.S-1333-23721210.12March 16, 202010.14Third Amendment to Lease Agreement by and between the registrant and 99 Hayden LLC, dated August 4, 2021.10-Q001-3926410.3August 5, 202110.15+Offer Letter Agreement by and between the registrant and Keith Regnante, dated as of February 7, 2020.S-1333-23721210.13March 16, 202010.16+Employment Agreement by and between the registrant and Jasbir Seehra, dated as of March 31, 2020, effective as of April 13, 2020.S-1/A333-23721210.14April 1, 202010.17+Employment Agreement by and between the registrant and Keith Regnante, dated as of March 31, 2020, effective as of April 13, 2020.S-1/A333-23721210.17April 1, 202010.18+Employment Agreement by and between the registrant and Simon Cooper, dated as of July 30, 2021 effective as of August 2, 2021.8-K001-3926410.2August 2, 202110.19+Employment Agreement by and between the registrant and Christopher Rovaldi, dated as of January 28, 2022 effective as of February 1, 2022.8-K001-3926410.1January 31, 202210.20+First Amendment to the Employment Agreement by and between the registrant and Keith Regnante, dated as of January 1, 2022.10-K001-3926410.21March 9, 202210.21+First Amendment to the Employment Agreement by and between the registrant and Simon Cooper, dated as of January 1, 2022.10-K001-3926410.22March 9, 202210.22Indenture of Lease by and between the registrant and Revolution Labs